qPCR Feb 23, 2021 Biocept, Protean BioDiagnostics Team up to Study EGFR Assay in Lung Cancer Feb 9, 2021 Spanish Cancer Company Universal Dx to Commercialize Methylation Method for Lung Cancer Detection Premium Nov 4, 2020 Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia Premium May 27, 2020 Bio-Me Eyes PCR-Based Microbiome Profiling Technology for Future CDx Premium Apr 22, 2020 Bio-Me Awarded $2.2M to Develop Microbiome Biomarker Test for Cancer Immunotherapy Feb 21, 2020 Genetron Health, InnoCare Partner on Cancer Clinical Trial Testing, CDx Development Aug 2, 2019 Comparison of KRAS Liquid Biopsy Kits Confirms Differences at Low Mutant Allele Fraction Jan 24, 2019 Noninvasive Prostate Cancer MDx Test Enters Validation Phase After Initial Results Published in JCO Premium Jan 16, 2019 Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug Aug 7, 2018 Researchers Integrate Genotyping Assay, Drug Delivery Tech for Precision Glioma Treatment Premium May 11, 2015 FDA Approves Roche KRAS Mutation Test for Metastatic Colorectal Cancer Patients Breaking News KSQ Therapeutics Begins Combination Dosing in Trial of USP1 Inhibitor for Advanced Solid Tumors Daiichi Sankyo Transfers Rights to Market Yescarta in Japan to Gilead Sciences Enhertu Shows Activity in Early-Stage HER2-Low Breast Cancer Patients in Study Reported at SABCS Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy
